Injection of GIP and GLP-2 may reduce bone resorption biomarker CTX in type 2 diabetes patients: Study
Denmark: A recent study published in The Journal of Clinical Endocrinology and Metabolism has shed light on the effects of exogenous glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) on burn turnover in patients with type 2 diabetes (T2D). The researchers revealed that the acute effects of exogenous GIP and GLP-2 on bone turnover are […]